Related Experiment Videos
[Mumps vaccines: virological basis]
Sozial- Und Praventivmedizin
|January 1, 1995
Abstract:
The prevention of mumps virus infection relies on the application of live, attenuated mumps virus vaccines. The process of attenuation from a wildtype mumps isolate to a safe vaccine has been empirical. A lower degree of attenuation results in solid immunity but carries an increased risk of post-vaccination meningitis due to the vaccine strain. Currently used vaccine strains are highly attenuated and essentially free of vaccine strain induced disease. However, their immunogenicity may be lower than previously reported.
Insights
Live, attenuated mumps virus vaccines prevent mumps infection. Highly attenuated vaccines reduce disease risk but may have lower immunogenicity than previously thought.
Area of Science:
- Virology
- Immunology
- Vaccinology
Context:
- Mumps virus infection prevention relies on live, attenuated vaccines.
- Vaccine attenuation from wildtype isolates has been an empirical process.
- Balancing vaccine safety and efficacy is crucial.
Purpose:
- To review the characteristics of live, attenuated mumps virus vaccines.
- To discuss the relationship between attenuation degree, immunity, and adverse events.
- To evaluate the current understanding of mumps vaccine immunogenicity.
Summary:
- Lower attenuation provides stronger immunity but increases meningitis risk.
- Current mumps vaccines are highly attenuated, minimizing disease risk.
- The immunogenicity of currently used mumps vaccine strains might be lower than previously reported.
Impact:
- Informs vaccine development and strain selection strategies.
- Highlights the need for ongoing assessment of vaccine effectiveness.
- Contributes to public health strategies for mumps prevention.